| Literature DB >> 27324061 |
Amirhossein Sahebkar1, Maria-Corina Serban2, Anna Gluba-Brzózka3, Dimitri P Mikhailidis4, Arrigo F Cicero5, Jacek Rysz3, Maciej Banach6.
Abstract
The present review provides an up-to-date summary of the findings on the lipid-lowering effects of the most important nutraceuticals and functional foods. Based on current knowledge, nutraceuticals might exert significant lipid-lowering, and their use has several advantages: A number of important questions remain to be addressed, including whether longer durations of therapy would result in a better response and the exact safety profile of nutraceuticals, especially at doses higher than those consumed in an average diet. Additionally, data regarding the effects of nutraceutical supplementation on the incidence of cardiovascular outcomes are lacking, and it is not clear whether additional lipid lowering by nutraceuticals can modify the residual cardiovascular risk that remains after statin therapy.Entities:
Keywords: Atherogenic dyslipidemia; Functional foods; Lipids; Nutraceuticals
Mesh:
Substances:
Year: 2016 PMID: 27324061 DOI: 10.1016/j.nut.2016.04.007
Source DB: PubMed Journal: Nutrition ISSN: 0899-9007 Impact factor: 4.008